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AUTONOMIC NERVOUS SYSTEM FUNCTION IN CHILDREN AND 
ADOLESCENTS WITH PRIMARY HEADACHE DISORDERS 
 
ASHWINI PRASANNA MULGAONKAR 
ABSTRACT 
  
The relationship between autonomic dysfunction and primary headache disorders 
has been established in the adult population. The aim of this retrospective study was to 
elucidate if there was a similar association in the pediatric primary headache population. 
Three groups were compared – migraine patients, tension-type headache patients and 
idiopathic scoliosis patients as a control group. Utilizing clinical data collected during 
patients’ initial visits, prevalence of autonomic dysfunction symptoms were quantified. 
The headache groups also filled out the Functional Disability Index (FDI) as well as the 
Children’s Depression Inventory (CDI) to help elucidate if there was a relationship 
between function disability, psychiatric state and primary headaches and/or autonomic 
dysfunction symptoms. It was found that the headache groups had significantly greater 
dysautonomia as compared to the control group. Only slight differences were found 
between the migraine and tension-type patients in regards to dysautonomia. No 
significant differences were found in total FDI or CDI scores. These results illuminate a 
relationship between autonomic nervous system dysfunction and primary headache 
disorders in the pediatric population studied. Prospective studies and the development of 
standardized dysautonomia questionnaires will allow a more detailed autonomic 
dysfunction profile to be built for this population.  
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INTRODUCTION 
 
 Headaches are one of the most common complaints in the general population 1. 
Estimates of prevalence vary widely depending on the study, definition of headaches, 
measures used, population involved, and time period monitored. In a meta-analysis of a 
variety of international studies, Karli et al. (2006) reported that prevalence rates for all 
diagnoses of headaches in children and adolescents ranged from 19.5% - 93.3%. Females 
in this population are also more likely to suffer from headaches than males 2,3.The 
majority of the headaches seen in emergency rooms and doctors’ offices are primary 
headache disorders. Primary headache disorders refer to headaches with a lack of a clear 
underlying pathophysiology, trauma, or systemic disease 4,5. The two most predominant 
primary headaches diagnosed are tension-type headache (TTH) and migraines (M) 3–6.  
Significant headaches are often associated with emotional distress, sleep 
impairments, gastrointestinal complaints, neck and shoulder pain and disturbances in 
school behavior and performance as compared to those children without chronic illnesses 
6–11. The 2010 Global Burden of Disease, released in December 2012, ranked migraine as 
the foremost disabling neurological disease 12,13. During childhood and adolescence, 
many hormonally-driven psychological and physiological changes occur. Some 
researchers suggest that chronic pain may affect these changes negatively and hinder 
proper development 14. Many studies have examined the impact and relationship of 
various life-stressors on the presence of headaches. Straube et al. (2013) concluded that 
certain critical events at school, socially and academically, and at home may contribute to 
 2 
 
the development of somatic problems. The negative impact of chronic headache pain has 
been likened to the negative impact of other chronic conditions, such as arthritis or 
cancer. Both have been found to adversely affect the lives of children and adolescents to 
a similar degree 10,14. 
 Researchers have also found certain co-morbidities that are frequently present in 
children and adolescents with chronic headaches – gastrointestinal problems, 
inflammatory conditions such as asthma and allergies, and psychiatric issues such as 
depression and anxiety may provide important information regarding the clinical and 
pathological development of these headaches 1,10. These pediatric issues may prolong 
headache-related disability into adulthood. A five-year follow up study by Camarda et al. 
(2002) reported that 56.2% of children who had migraines continued to suffer through 
adolescence 15. Knook et al. (2012) found that children with chronic pain and related 
psychiatric disorders had an increased prevalence of psychiatric disorders continuing 
through late-adolescence and into adulthood 16. There is a higher incidence of both types 
of headaches predicted in adulthood when a childhood diagnosis of primary headaches, 
M or TTH, is made 1. It is also important to note the socioeconomic impact of living with 
a chronic pain condition extending throughout adulthood. In the U.S., it has been 
estimated that medical costs, and the consequential loss of productivity (a reduction of 
3.5 hours per week) result in an economic impact of approximately $61.2 billion per year 
17–20. Comprehensive and early treatment of pediatric headaches may be able to prevent 
this future economic, social, and emotional burden. 
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A. The Autonomic Nervous System 
The autonomic nervous system (ANS) is the branch of the peripheral nervous system 
that acts as the control system for physiological activities necessary for daily living. 
Generally functioning involuntarily, the ANS regulates the respiratory, cardiovascular, 
digestive and endocrine systems. It can be affected by exogenous stressors originating 
from outside the body, such as temperature or social factors, as well as endogenous 
stressors arising from inside the body, such as hormones. The ANS has two branches – 
the parasympathetic and the sympathetic nervous systems (PSNS and SNS, respectively) 
which operate independently as well as in coordination with each other. The balance of 
interactions between the two branches is very important in maintaining proper function of 
the organs they innervate. Numerous studies using functional-Magnetic Resonance 
Imaging (fMRI) and other imaging techniques have identified specific brain regions 
responsible for various autonomic functions. Within the brain, the ANS is located in the 
medulla oblongata in the lower brainstem. The hypothalamus, located directly above the 
brainstem, is important as it is the location for the integration and regulation for all 
autonomic functions 21–23. 
Due to the autonomic nervous system’s intimate involvement in many day-to-day 
activities, dysfunction in the ANS can have widespread negative effects. Any problem 
affecting the sympathetic or parasympathetic branch or an imbalance between the two, an 
inhibition or hyper-activation, results in dysautonomia. Examples of dysautonomic 
symptoms include abnormal blood pressure, gastric stasis, vertigo, nausea, disordered 
sleep and pulse rate variation. Diseases can develop as a result of autonomic dysfunction, 
 4 
 
or autonomic dysfunction may be a symptom of certain diseases. Measuring these 
symptoms via standardized autonomic function testing protocols cannot discern the cause 
or source of the disease, but may be useful in monitoring its severity and for modifying 
treatment 24–27.  
Stress is a variable that is coordinated in part by the autonomic system. In a group of 
young children, it was found that heart rate variability (HRV), a function controlled by 
the ANS, was a valid indicator of the child’s stress levels. A lower HRV, indicated an 
imbalance between the PSNS and SNS branches, and correlated with a higher level of 
reported-stress and abnormal cortisol levels 28. Juvenile patients with Chronic 
Widespread Pain Syndrome, Postural Orthostatic Tachycardia Syndrome (POTS), and 
Small-Fiber Polyneuropathy also present autonomic dysfunction symptoms 29,30. In these 
cases, autonomic testing has proven to be a valid tool to monitor and identify variances 
and severity of condition, resulting in better treatments for the patients.  
Postural Orthostatic Tachycardia Syndrome (POTS) is caused by decreased cerebral 
perfusion and increased sympathetic activation, causing an imbalance in the autonomic 
system. Autonomic dysfunction criteria for this condition have been identified in the 
adult-population and recently, a pediatric profile has been defined 30,31 Nisbet et al. 
(2013) pursued a similar goal within the adult-Sleep Disordered Breathing (SDB) 
population. Using autonomic testing measures, they identified dysautonomic symptoms 
in the pediatric-SDB population 31. In these conditions, it was found that the adult 
profiles, though similar, did not accurately represent the presentation in children and 
adolescents.  
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B. Chronic Headache Etiology  
Primary headaches are central nervous system disorders involving the activation of 
the trigeminovascular system and its connections to regions of pain transmission. As the 
stimulation is passed through the brain, further connections are made to the entire 
autonomic system 32–38. The then deregulated autonomic system results in a variety of 
symptoms that disrupt everyday life, including irregular heart rate, dizziness, or gastric 
irregularity. 
Migraine is a complex neurovascular disorder that initiates via an unspecified-trigger 
in the central nervous system with spread to the trigeminal vascular pathway 1,39. There 
has been evidence linking these triggers with the release of calcitonin gene-related 
peptide (CGRP), which closely links the trigeminovascular system to migraine pain 32–34. 
Many other triggers may play a role in the initiation of the event, such as stress, fatigue, 
and illnesses 5. Recent neuroimaging has elucidated a migraine active region within the 
brainstem 23. There are strong indications for a hereditary component as genomic regions 
linked to migraine prevalence have been identified in neurological, vascular, and 
hormonal pathways 40,41.  
Migraines are diagnosed via medical history and examinations and rarely require 
neuroimaging. Migraine pain is characterized by recurrent pulsating, unilateral headaches 
accompanied by sensory sensitivity made worse by physical activity 4. Migraines present 
with or without an aura, a transient sensory disturbance directly before or during the 
headache. The aura has been attributed to an electrophysiological event termed cortical 
spreading depression (CSD) caused by a wave of neuronal activity followed by inhibition 
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slowly spreading over the cortical regions of the brain. Many researchers have found that 
migraines without aura are more common than those that present with aura 1,39,40. 
Tension-type headaches are also associated with a disorder in the central nervous 
system, specifically, the sympathetic nervous system, and results in a secondary 
sensitization of the trigeminal neuronal pain pathway 4,35,42. TTH is the most common 
type of headache though it is generally less disabling and therefore less diagnosed 5. TTH 
present with bilateral, non-pulsatile pain without sensory sensitivity and can occur with 
or without muscle tenderness 4. The etiology of TTH is not well understood. Some 
theories predict the same stressors involved in the development of migraine play a role, 
but to a lesser degree. Another hypothesis states a possible role of excess Nitric Oxide 
(NO) generation causing central sensitization and therefore resulting in an increased 
sensitivity to the impulses 5,43. Recent research has postulated that the sensitization may 
occur via chronic pericranial myofacial tenderness and nocioceptive input 44,45.  
 
C. Evidence of ANS Dysfunction in Headache Patients  
Autonomic function testing protocols have been validated for both the adult and 
pediatric populations 24,25,27. These studies have shown the positive impact autonomic 
testing may have on the treatment of certain autonomic-driven diseases. Multiple reports 
in adult-headache literature have used validated autonomic dysfunction measures to 
analyze ANS function in that population 24,42,46. As compared to non-headache controls or 
to non-chronic headache patients, chronic M and chronic TTH patients were found to 
have greater autonomic dysfunction – lowered parasympathetic NS activity and elevated 
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sympathetic NS activity 24,42,46. In the pediatric population, ANS dysfunction is now 
commonly reported in studies of Postural Orthostatic Tachycardia Syndrome, Diabetic 
Peripheral Neuropathy, Complex Regional Pain Syndrome, and a predominantly pediatric 
headache syndrome – Cyclic Vomiting Syndrome 29,30,47,48. Due to the fact headaches are 
common symptoms in many of these syndromes and the overwhelming evidence found in 
the adult-research, headaches are likely linked to autonomic dysfunction. Recently, 
Straube et al. (2013) indicated a few key differences in the presentation of pediatric 
migraine as compared to in the adult population. Recurrent nausea, episodes of 
abdominal pain, introverted behavior, and recurrent attacks of vertigo are predominantly 
pediatric presentations 1. As per the findings in other autonomic dysfunction-related 
disorders, such as POTS and SDB, it may be possible to develop a specific pediatric-
migraine and TTH profile in order to better identify and treat these patients.  
 
D. Classifying and Diagnosing Chronic Headaches and Associated Issues 
a. Headaches  
The diagnosis of headaches is hierarchical; the more information that can be 
provided about the onset, duration, and location of the pain allows for a more specific 
classification. A primary headache diagnosis is a first-digit level diagnosis. That group 
includes migraines, tension-type headaches and cluster headaches. Identifying one of 
those three is called a second-digit classification. A standardized, generally accepted 
classification system has been established by The International Classification of 
Headache Disorders, now on its second edition (ICHD-2) 4,49.  
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Figure 1. Diagnosis of Pediatric Migraine With and Without Aura as Defined in the 
ICHD, 2nd Edition. 
 
These are the criteria for diagnosis pediatric of migraine with or without aura. A 
pediatrician or neurologist would obtain this information through a clinical visit and a 
thorough medical history. 
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Figure 2. Diagnosis of Pediatric Tension-Type Headache as Defined in the ICHD, 
2nd Edition. 
 
These are the criteria for diagnosis of pediatric tension-type headache. A pediatrician or 
neurologist would obtain this information through a clinical visit and a thorough medical 
history. 
 
b. Functional Disability Index (FDI) 
The Functional Disability Index (FDI) was developed to assess illness-related 
disability in children and adolescents. The various measures of disability gauge the 
impact on everyday functioning and the extent to which the illness affects the family. The 
FDI has been validated in the assessment of acute and chronic pediatric pain 50. The FDI 
scores have been validated as demonstrating stability over a three month period in 
chronic patients. The pediatric 15-item instrument asks the rater’s perception of their ease 
of activity over the past two weeks. Each question is answered on a Likert-scale of 
difficulty – “No trouble” = 0, “A little trouble” = 1, “Some trouble” = 2, “A lot of 
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trouble” = 3, and “Impossible” = 4. A sum score of zero indicates that the rater finds none 
of the activities difficult and can complete them all with ease. A parallel parent form 
which asks parents to rate the extent of their child’s disability over the past two weeks 
has also been validated and standardized 50,51. 
c. Children’s Depression Inventory (CDI) 
The Children’s Depression Inventory (CDI) is a self-report, symptom-oriented, 
27-item questionnaire that helps assess cognitive and behavioral signs of depression. The 
scale is suitable for children and adolescents ages 7-17 years old. This scale is sensitive to 
changes in depressive symptomology over time and can also be used to assess severity of 
symptoms. A total score is calculated of which a T-score over 65 indicates potential 
clinical depression. The CDI also calculates scaled scores for Negative mood, 
Interpersonal Problems, Ineffectiveness, Anhedonia, and Negative Self-esteem. A parallel 
parent form directs the parent(s) to rate the extent of their child’s depressive symptoms.  
Authors suggest incorporating these results with other information gathered from a 
comprehensive medical and psychological evaluation of the patient before drawing any 
conclusions 52. In this study, patients were administered the first edition of the CDI 
questionnaire.   
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GOALS 
 
A. The Pediatric Headache Program  
The Pediatric Headache Program (PHP) at Boston Children’s Hospital in Waltham is 
a unique collaboration between the Neurology and Anesthesia departments. Here, 
children and adolescents with chronic or intractable headaches are seen by neurologists 
and psychologists and are provided with a multidisciplinary evaluation. During the initial 
visit, each member of the team meets with the family to fully understand the problems 
and identify any specific triggers, both medical and psychological. Families are then 
provided comprehensive information on a wide variety of treatment options including 
medications, cognitive-behavioral therapies, psychological counseling, or alternative 
therapies such as acupuncture. Due to the strong evidence linking the autonomic system 
and the trigeminovascular system, the clinic hopes to quantify autonomic dysfunction in 
its patients. Such information has the potential to improve targeted-therapies and 
treatments.   
 
B. Aims 
Compared with data in the adult-headache population, there are few reports that 
describe the presentation of autonomic dysfunction in pediatric-headache patients. The 
main goal of this project is to develop an autonomic dysfunction profile for the pediatric 
primary headache population. If dysautonomia symptoms are prevalent at these patients’ 
first visit to the PHP, monitoring their autonomic system function throughout treatment 
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will prove to be an important clinical tool. This study will look at the following 
objectives: 
1. To determine if the autonomic nervous system has a relationship with pediatric 
primary headache disorders by comparing the prevalence of autonomic 
dysfunction symptoms in a headache group versus a control non-headache group 
a. Symptoms: constipation, insomnia, dizziness/orthostasis, blurry vision, 
hyperhidrosis/ excessive cold in hands or feet, and abnormal blood pressure 
2. To determine if prevalence of dysautonomia in pediatric primary headache 
patients is related to a higher reported functional disability via the Functional 
Disability Index questionnaire  
3. To determine if pediatric migraine patients have more prevalent autonomic 
dysfunction symptoms and/or higher reported functional disability than pediatric 
tension-type headache patients 
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METHODS 
 
A. Study Design 
This retrospective study reviewed the records of patients seen at Boston Children’s 
Hospital between 2009 and 2013. The patients in the migraine and tension-type headache 
groups were diagnosed either by neurologists at the PHP or by a local (Boston-area) 
neurologist and then referred to the PHP. Headache classifications were made using the 
ICHD-2 4,49. The presence of autonomic dysfunction symptoms was extracted from the 
patient’s clinical data recorded during their initial evaluation at the PHP. This clinical 
data was obtained via a patient-doctor interview in which all of the bodily systems, 
including the autonomic nervous system, are reviewed. During their first visit to the PHP, 
patients also filled out questionnaires, including the FDI and CDI.  
Patients in the control group all had a diagnosis of “Idiopathic Scoliosis” (IS) and 
were seen in the Orthopedic Clinic at Boston Children’s Hospital. It was important to 
pick a control group with no autonomic nervous system dysfunction but which also had 
medical records that could be queried. Idiopathic scoliosis is diagnosed only if the 
neurological exam is normal and there are no unusual presentation symptoms. Juvenile 
idiopathic scoliosis is diagnosed in those patients aged 3 – 10 years old while adolescent 
idiopathic scoliosis, the most common type of IS, is found in those patients older than 10 
years old 53. This group also rarely presents with other comorbidities or pathologies, 
making them a fairly uncomplicated medical group and long-term follow up shows little-
to-no functional impairment 54–57. This population was chosen as the control group due to 
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the fact that they are a clinically-simple non-headache presenting group that there are 
medical records for.  
Exclusionary criteria were based on disorders with known involvement of the 
autonomic system. Patients were excluded from all groups for the following conditions: 
 Primary headache diagnosis other than migraine or tension-type headache 
 Major Anxiety or Major Depressive Disorder diagnosis  
 Diabetes diagnosis  
 Inherited peripheral neuropathy 
 Familial Dysautonomia diagnosis  
 Congenital Heart Disease diagnosis 
 History of uremia 
 History of vitamin deficiency  
 History of Lyme Disease  
 HIV diagnosis 
 History of Celiac Disease, Lupus or Arthritis  
 Inflammatory Bowel Disease diagnosis 
 
B. Statistical Analysis 
Statistical analysis included univariate comparisons based on Student T-Test for age 
and Fisher’s Exact Tests for comparing binomial proportions as well as logistic 
regression to identify the symptoms independently associated with headache (to control 
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for possible confounding). Symptoms that are found to differentiate pediatric headache 
and scoliosis groups were summarized using odds ratios and 95% Confidence Intervals 
(CI). Functional disability was assessed using physical and social activities obtained from 
the Functional Disability Index questionnaire. Headache and scoliosis groups were 
compared using Fisher’s Exact Test to assess whether presence and type of headache 
interfere with lifestyle activities (as a surrogate for quality of life). Statistical analysis was 
performed using IBM SPSS Statistics (version 21.0, IBM, Armonk, NY). Two-tailed P < 
0.05 was considered statistically significant.   
Power analysis indicated that a sample size of 100 patients with headache (50 
migraine, 50 tension-type) and 100 age-and gender-matched scoliosis controls would 
provide 80 power to detect a difference of 25% in each of the following symptoms - 
constipation, insomnia, dizziness/orthostasis, blurry vision, hyperhidrosis/ excessive cold 
in hands or feet, and abnormal blood pressure, between the groups using Pearson Chi-
Square (overall test) and Fisher’s Exact Test for pairwise comparisons using a two-tailed 
alpha level of 0.05 (version 7.0, nQuery Advisor, Statistical Solutions, Saugus, MA). 
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RESULTS 
 
The headache group contained 125 individuals (54 males, 71 females, mean age 
13.9) and the control/IS group contained 106 individuals (33 males, 73 females, mean age 
12.6). Of the headache group, 68 individuals were diagnosed with M (37 males, 31 
females, mean age 13.1, st. dev. 3.0) and 57 were diagnosed with TTH (17 males, 40 
females, mean age 14.7, st. dev. 2.6).  
Table 1 shows the mean ages and standard deviations for each group. During 
post-hoc analysis using the statistical Bonferroni method, the TTH group was 
significantly older than the M group (p=0.002) and the control group (p<0.001). This 
correlates with the information found in the literature regarding TTH, M and IS ages. 
Table 1 also shows the gender frequency within each group. There was no significant 
gender differences found between the groups. 
 
Table 1. The mean ages, st. dev., and gender frequency of the patient groups.  
 
 
 
 
 
Group (mean age ± st. dev) Male (%) Female (%)
Migraine (13.1 ± 3.0) 54.40% 45.60%
Tension-type (14.7 ± 2.6) 29.80% 70.20%
Control (12.6 ± 2.5) 31.10% 68.90%
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The ANS dysfunction symptoms collected were tabulated and their prevalence 
compared group-wise. For most of the symptoms investigated, the headache group (M 
and TTH combined) presented with significantly more dysautonomia than the control 
group. Those symptoms were “constipation,” “insomnia,” “dizziness/orthostasis,” and 
“hyperhidrosis/excessive cold in extremities” (Figure 3). Within the headache group (M 
and TTH combined), “hyperhidrosis/excessive cold in hands and feet” was the most 
endorsed symptom and “abnormal BP” was the least endorsed symptom.  
Comparing the two headache groups individually (M and TTH separately) against 
the control group yielded more specific differences. The TTH group presented with 
significantly more dysautonomia as compared to the control group in five of the 
symptoms except for “abnormal blood pressure.” The M group presented with 
significantly more dysautonomic symptoms only in regards to “insomnia,” 
“dizziness/orthostasis,” and “hyperhidrosis/excessive cold in extremities” were 
significantly different. When comparing within the headache group (M versus TTH), TTH 
presented with significantly greater dysautonomia in regards to “blurry vision” and 
“hyperhidrosis/excessive cold in extremities.” 
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Figure 3. The prevalence of ANS dysfunction symptoms across all three patient 
groups.  
 
The black bar in this graph represents the percent of patients in the migraine group, the 
grey bar represents the percent of patients in the tension-type group, and the vertical 
striped bar represents the percent of patients in the control group with the specified ANS 
dysfunction symptom. All of these symptoms were collected via doctor-patient interview. 
* = significantly greater dysautonomia in the specified group as compared to the control 
group (p≤0.006) 
ⱡ = significantly greater dysautonomia in the TTH group as compared to the M group 
(p≤0.03) 
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Within the 125 headache patients, 94 (75.2%) completed the Functional Disability 
Index questionnaire (45 M, 49 TTH) and 88 (70.4%) completed the Children’s 
Depression Inventory questionnaire (47 M, 41 TTH).  
Table 2 presents data from the FDI questionnaire given to all headache patients 
during their first visit to the PHP. The sum score is out of 15 questions with a score of 0-4 
possible points each. The highest possible sum score on the FDI is 60. The functional 
disability between the M and TTH groups were found not be significantly different. 
 
Table 2. The mean FDI sum score, st. dev. and ranges for both the M and TTH 
groups. 
This table presents the mean FDI sum score, standard deviation, and range for the M and 
TTH groups.  
 
 
 
 
 
 
 
 
 
 
Mean St. Dev. Range
Migraine 20 14 0-48
Tension-type 17 10 0-38
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Looking at each FDI item individually can provide interesting information on the 
difficulty of these various activities. Each item can be scored on a scale between 0 and 4 
(0 signifying the patient can complete the activity with “no trouble”, 4 signifying the 
activity is “Impossible” for the patient to do). Analysis showed that the mean score of 
each item fell in the range of 0 – 2 for both the M and TTH patients. Using this range to 
map the each mean item score on a scale from 0 (representing activities that were easier 
for the patients to do, specifically a mean score of 0-0.5) to 2 (representing activities that 
were harder for the patients to do, specifically a mean score of 1.5-2) we can see which 
activities/items were harder for these patients than others. By separating these scores by 
primary headache diagnosis, we can identify which items were easy/hard for both groups 
or for a particular group over the other (Figure 4, A) 
Forty percent of the items/activities were difficult for both the M and TTH groups 
as their mean scores were greater or equal to 1.5. These harder items/activities were 
“being up all day,” “being at school all day,” “doing activities in gym/sports,” “reading or 
doing homework,” “running the length of a football field,” “getting to sleep at night and 
staying asleep.” One item/activity was found to be easier for both groups with its mean 
score of less than or equal to 0.5 – “walking to the bathroom.” The map also shows us 
that there are some activities that are endorsed differently between the two groups. For 
example, “doing something for a friend” is harder for the M group (mean score = 1.6) 
than it is for the TTH group (mean score = 1.2). Also, the TTH group finds “walking up 
the stairs” (mean score = 0.5) and “walking the length of a football field” (mean score = 
0.5) easier than the M group (mean scores = 0.8, 0.9, respectively).  
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Figure 4. The mean FDI scores for each item for both the M and TTH groups.  
 
The X axis represents each FDI item. The Y axis represents the mean score for that item. 
Though each item could be scored from 0 (“No trouble”) to 4 (“Impossible”), the mean 
scores of the M and TTH groups had a range of mean values from 0-2. The lower scores, 
0-0.5, indicated the activities that were easier for these patients to do while the higher 
scores, 1.5-2, indicated the activities that were harder for these patients to do. By plotting 
both the M and TTH item scores on the same chart, the items/activities that were 
easier/more difficult for the groups are elucidated.  
 
Figure 5, A and B indicate visually indicate that the M group found less items 
easier (mean score of ≤ 0.5) than the TTH group did – one item/activity versus three 
items/activities, respectively. The M group also found more items/activities difficult 
(mean score of ≥ 1.5) than the TTH group did – seven items/activities versus six 
items/activities, respectively.  
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Figure 5. The ratio of harder, easier and moderate items/activities for both the M 
and TTH groups. 
 
 
These figures represent ratio of harder, easier and moderate items/activities asked on the 
FDI per primary headache diagnosis. Harder items were items that had a mean score of 
1.5-2. Easier items/activities had a mean score of 0-0.5. Moderate items/activities had a 
mean score between 0.5-1.5.  
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Table 3 presents data from the CDI questionnaire given to all headache patients 
during their first visit to the PHP. There are five sub-scale totals, Negative Mood, 
Interpersonal Problems, Ineffectiveness, Anhedonia, and Negative Self Esteem which 
provide specific information on the patient’s psychological state. The M group’s median 
Interpersonal Problems sub-total score was significantly greater than the TTH group’s 
median score. In all the other sub-total scores as well as in the total CDI score, the M and 
TTH groups did not score significantly differently. It is interesting to note though that the 
range of scores in the TTH group for Negative Mood, Ineffectiveness, Anhedonia, 
Negative Self Esteem and total CDI score were wider than in the M group.  
 
Table 3. The median CDI sub-total scores, total score and ranges for both the M and 
TTH groups. 
This table presents the sub-total scores, total CDI score as well as their individual ranges 
for both the M and TTH groups. 
 
Negative 
Mood
Interpersonal 
Problems Ineffectiveness Anhedonia
Negative Self 
Esteem
Total CDI 
Score
Migraine 1 (0-8) 1 (0-3) 2 (0-4) 4 (0-7) 0 (0-5) 7 (0-22)
Tension-type 2 (0-10) 0 (0-2) 2 (0-6) 4 (0-11) 1 (0-7) 9 (1-32)
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DISCUSSION 
 
Finding a specific pathophysiological etiology for primary headaches has been at 
the forefront of chronic pain research for many years. In the adult population, autonomic 
dysfunction has been confirmed to have a relationship with primary headaches, such as 
migraines and tension-type headaches. Unfortunately, there is limited pediatric primary 
headache research regarding autonomic dysfunction. This project was designed to 
elucidate a relationship between dysautonomia and primary headaches retrospectively. If 
significant autonomic dysfunction is found in children and adolescents with migraine and 
tension-type headaches, it may be beneficial to measure these symptoms prospectively as 
clinical tools.  
As a combined headache group (M and TTH), most symptoms were significantly 
different than the control group, except for “blurry vision” and “abnormal blood 
pressure.” When investigated separately, the TTH group had a significantly higher 
prevalence of dysautonomia as compared to the control group in all symptoms except 
“abnormal blood pressure.” The M group only showed significantly greater prevalence of 
“insomnia,”  “dizziness/orthostasis” and hyperhidrosis/excessive cold in extremities.” 
The headache group’s higher overall prevalence of dysautonomia lends support to the 
hypothesis that the ANS plays a role in primary headache disorders.  
Contingent upon this retrospective review’s detection of significant dysautonomia 
symptoms among headache patients, another aim of this study was to define an ANS 
dysfunction profile for pediatric migraine and tension-type headache patients. Only slight 
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differences were found between these two groups. The TTH group presented with 
significantly more dysautonomic features in only two out of the six symptoms, 
specifically “blurry vision” and hyperhidrosis/excessive cold in extremities.” Autonomic 
dysfunction is reported for patients with primary headaches, but further investigation is 
needed to elucidate a more specific profile of dysfunction for each headache subtype.  
Another aim of this study was to associate level of functional disability with level 
of autonomic dysfunction. Prior research on chronic pain conditions have shown that 
living with these symptoms may effect one’s mental, emotional, and physical well-being 
and may be especially harmful to younger patients 14. Quantifying the level of ANS 
dysfunction and headache may have a positive impact on these patients’ daily lives. This 
variable was measured by the Functional Disability Index (FDI); a self-reported 
questionnaire where the subject rates how difficult it is for them to complete certain 
activities or tasks 50,51. The FDI was given to the headache patients on their first visit to 
the PHP, the same day their nervous system function interview was conducted.  
The mean FDI sum score of the two headache groups was not significantly 
different, meaning that their average functional disability is roughly at the same level. 
Out of a total high sum score of 60, the mean sum score within the headache group was 
18.49. By mapping the individual mean scores of each item/activity one may find the 
items/activities that are most disabling within the M and/or TTH groups. Many of the 
items/activities were endorsed at the same or similar levels by the M and TTH groups. 
Six out of a total 15 items (40%) were endorsed on the more difficult side of the 
spectrum, meaning that these activities are found to be challenging by the pediatric-
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primary headache population, regardless of specific diagnosis. For example, “being up all 
day,” “being at school all day,” “doing activities in gym/sports,” “reading or doing 
homework,” “running the length of a football field,” and “getting to sleep at night and 
staying asleep” were endorsed on the more difficult side of the spectrum for both groups.  
There were also some activities that were endorsed differently by the two groups. For 
example, “walking the length of a football field” was scored as more difficult for the M 
group than it was in the TTH group. This information may be useful for clinicians as a 
measure of treatment efficacy. The FDI questions discuss common, everyday activities, 
and if therapies or treatments can target these endpoints, the quality of life of these 
children and adolescents may improve. 
Along with functionality, the psychological concerns of these patients are also 
important. Mood was measured via the Children’s Depression Inventory (CDI) which 
asks about various thoughts the patient might have had about him or herself. This data 
provides information on levels of Negative Mood, Interpersonal Problems, 
Ineffectiveness, Anhedonia, and Negative Self Esteem 52. Those patients with a diagnosis 
of Major Depression or Major Anxiety were excluded from this study due to potential 
ANS involvement in those conditions.  
There was no significant difference between the two headache groups in regards 
to their total CDI scores. Out of a total high score of 54, the mean score of both groups 
was not higher than ten. It is interesting to note, however, that in the TTH group, the 
range of total scores was wider than in the M group, by ten points. One explanation for 
this finding might be due to the TTH group having a more variable depression profile. An 
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extended period of this low level of chronic depression may lead to a variety of negative 
outcomes when initiated at a young age. These problems may manifest themselves 
socially and via self-perception, ultimately affecting mental and social development 6,58. 
In the adult headache population, a high rate of depression is prevalent 59–62. One 
explanation may be due to the fact that younger children and adolescents may have a 
more difficult time quantifying their emotional state for a questionnaire. Due to the low 
level of depression found throughout this population and the prevalence of depression 
found in the adult population, the mental state of these patients should be carefully 
monitored throughout their treatments to better determine when and why this change 
occurs. 
Retrospectively quantifying dysautonomia symptoms is limited by patient 
interpretation and physician report. For example, it is difficult to standardize a definition 
of “blurry vision” in an interview format. In other areas of pediatric autonomic 
dysfunction research, such as in POTS and Diabetes research, autonomic dysfunction 
measuring protocols have shown clinical utility, such as tilt-table testing, HRV 
measurements, the Valsalva maneuver, and sudomotor testing 29–31,47. Even though this 
retrospective method of data collection may have limitations, a significant relationship 
between the presence of autonomic dysfunction symptoms and pediatric primary 
headaches were found. It is valid to further explore the prevalence of these symptoms by 
measuring them in a prospective study. 
Due to the autonomic nervous system’s involvement in many different bodily 
systems, there are many ways dysfunction may present itself. For example, there can be 
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an imbalance in the signal to the heart causing an elevated or lowered heart rate, the 
innervations to the lungs may be affected causing disordered breathing patterns, or the GI 
system can be affected resulting in delayed gastric emptying or excessive emptying 32,63–
65. The autonomic dysfunction symptoms collected are only a small subset of the many 
symptoms possible. The symptoms chosen were decided based upon their prevalence in 
the adult-headache population literature, as well as their ability to be measured 
prospectively. One possible reason for minimal difference between the migraine and 
tension-type headache groups may be attributed to the particular symptoms selected for 
study. Measuring patients’ levels of dysautonomia, and utilizing validated autonomic 
function protocols, would allow a more comprehensive collection of symptoms, thus 
leading to a more specific ANS dysfunction profile for both migraine and tension-type 
headache patients.  
Careful review of these patient histories and self-reported symptoms highlighted 
the intrinsic complexity of the ANS. Along with prospectively measuring these 
symptoms with validated measures, developing a standardized clinical questionnaire for 
physicians would help synthesize information. A consistent method for quantifying self-
reported data would give more clinical meaning to that information.  
The autonomic nervous system’s integrated involvement throughout the body 
caused another limitation when selecting a control group for this study. This study 
required a control group with non-headache symptoms, no possible autonomic nervous 
system involvement and a full clinical evaluation. These requirements ruled out many of 
the most prevalent pediatric conditions for example, asthma and allergies 66,67. Patients 
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with a diagnosis of idiopathic scoliosis commonly present with no other comorbidities. 
Though a comparison group of healthy controls is ideal; due to the retrospective, clinical 
evaluation-requirement of this study, the IS group was a thoroughly investigated 
alternative.  
During this retrospective review, some additional findings requiring future 
investigation were found. For example, the level of “insomnia” was significantly elevated 
in both M and TTH groups. As insomnia is a complex diagnosis in itself, it would be 
valuable to investigate that relationship further.  
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CONCLUSION 
There is very little information published regarding the role of the autonomic 
system in pediatric-primary headache disorders. This project is an initial step towards 
confirming a relationship. It suggests that development of an autonomic dysfunction 
profile for this population utilizing validated measures, such as HRV, tilt table testing, 
and sudomotor testing, may be clinically relevant. By collecting this information we will 
also be able to more specifically define ANS dysfunction in patients suffering from 
migraines versus tension-type headaches. This information will not only help clinicians 
monitor treatment effectiveness, it will also bring us closer to elucidating the underlying 
mechanisms causing primary headaches. 
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APPENDIX 
Functional Disability Index (FDI) 
When people are sick or not feeling well it is sometimes difficult for them to do their 
regular activities. In the last few days, would you have had any physical trouble or 
difficulty doing these activities? 
 
 
 
 
 
1. Walking to the bathroom
No 
Trouble
A Little 
Trouble
Some 
Trouble
A Lot of 
Trouble Impossible
2. Walking up the stairs
No 
Trouble
A Little 
Trouble
Some 
Trouble
A Lot of 
Trouble Impossible
3. Doing something with a 
friend (for example, playing a 
game)
No 
Trouble
A Little 
Trouble
Some 
Trouble
A Lot of 
Trouble Impossible
4. Doing chores at home
No 
Trouble
A Little 
Trouble
Some 
Trouble
A Lot of 
Trouble Impossible
5. Eating regular meals 
No 
Trouble
A Little 
Trouble
Some 
Trouble
A Lot of 
Trouble Impossible
6. Being up all day without a 
nap or rest
No 
Trouble
A Little 
Trouble
Some 
Trouble
A Lot of 
Trouble Impossible
7. Riding the school bus or 
traveling in the car
No 
Trouble
A Little 
Trouble
Some 
Trouble
A Lot of 
Trouble Impossible
8. Being at school all day
No 
Trouble
A Little 
Trouble
Some 
Trouble
A Lot of 
Trouble Impossible
9. Doing the activities in gym 
class (or playing sports)
No 
Trouble
A Little 
Trouble
Some 
Trouble
A Lot of 
Trouble Impossible
10. Reading or doing 
homework
No 
Trouble
A Little 
Trouble
Some 
Trouble
A Lot of 
Trouble Impossible
11. Watching TV
No 
Trouble
A Little 
Trouble
Some 
Trouble
A Lot of 
Trouble Impossible
12. Walking the length of a 
football field
No 
Trouble
A Little 
Trouble
Some 
Trouble
A Lot of 
Trouble Impossible
13. Running the length of a 
football field
No 
Trouble
A Little 
Trouble
Some 
Trouble
A Lot of 
Trouble Impossible
14. Going shopping
No 
Trouble
A Little 
Trouble
Some 
Trouble
A Lot of 
Trouble Impossible
15. Getting to sleep at night 
and staying alseep
No 
Trouble
A Little 
Trouble
Some 
Trouble
A Lot of 
Trouble Impossible
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Children’s Depression Inventory (CDI) 
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